NR3C2 and Nephropathy: Current drug therapies for HF, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and mineralocorticoid receptor antagonist can only slow the progression, and have extensive side effects, including cough, vomiting, skin itching, and aggravating kidney damage.